Hyperreflexia News and Research

RSS
Study highlights need to educate women and medical community about risk factors of preeclampsia

Study highlights need to educate women and medical community about risk factors of preeclampsia

Eisai, Arena complete two Phase 1 registrational trials for once-daily formulation of lorcaserin

Eisai, Arena complete two Phase 1 registrational trials for once-daily formulation of lorcaserin

Forest Laboratories, Pierre Fabre Laboratories announce that FETZIMA gets FDA approval for MDD

Forest Laboratories, Pierre Fabre Laboratories announce that FETZIMA gets FDA approval for MDD

Eisai submits BELVIQ NDS with Health Canada

Eisai submits BELVIQ NDS with Health Canada

Discovery of AVM can relieve pain due to chronic back pain and neurologic deficits

Discovery of AVM can relieve pain due to chronic back pain and neurologic deficits